abiraterone vs bazedoxifene/conjugated estrogens
Side-by-side comparison of abiraterone and bazedoxifene/conjugated estrogens Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread. It works by lowering the amount of androgen your body makes.
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body. It is used to treat menopause symptoms and prevent bone loss after menopause in women with a uterus.
Abiraterone is used to treat prostate cancer that has spread to other parts of the body. It is for cancers that are castration-resistant, meaning they no longer respond to hormone therapy alone. It is also used for high-risk castration-sensitive prostate cancer. You will take this medicine with prednisone.
Duavee is used to treat moderate to severe hot flashes caused by menopause. It can also help prevent bone loss (osteoporosis) after menopause. You should only use Duavee if you are at significant risk of osteoporosis and other non-estrogen medications should be carefully considered. Use Duavee for the shortest time that works for you, based on your goals and risks.
Abiraterone blocks an enzyme called CYP17, which your body needs to make androgens. Androgens can help prostate cancer grow. By blocking this enzyme, abiraterone lowers androgen levels and slows cancer growth.
Duavee contains two medicines. Estrogen helps with menopause symptoms and bone loss. Bazedoxifene blocks estrogen's effects in the uterus, which lowers the risk of uterine cancer that can happen when taking estrogen alone.
- • Feeling tired
- • Joint pain
- • High blood pressure
- • Feeling sick to your stomach
- • Swelling
- • Muscle spasms
- • Nausea
- • Diarrhea
- • Upset stomach
- • Upper abdominal pain
- Death 1,390
- Feeling tired 1,022
- Hot flash 678
- Weakness 562
- Worsening of disease 561
No adverse event reports.
Abiraterone can cause problems with mineralocorticoid excess, like high blood pressure, low potassium, and fluid retention. If you have heart problems, your doctor will monitor you closely. This medicine can also cause liver problems, which can be severe. Your doctor will check your liver function regularly. Do not take abiraterone with radium Ra 223 dichloride. Abiraterone can harm an unborn baby, so men should use effective birth control if their partner can get pregnant.
Duavee has serious warnings. It can increase the risk of uterine cancer, stroke, blood clots, and dementia. Women taking Duavee should not take additional estrogens. Estrogen should not be used to prevent heart disease or dementia. Talk to your doctor about the risks and benefits of Duavee.
Abiraterone can cause harm to an unborn baby. Men who are taking abiraterone should use effective birth control during treatment and for 3 weeks after the last dose if their partner is able to get pregnant. It is not known if abiraterone passes into breast milk.
Do not take Duavee if you are pregnant. It can harm your unborn baby. Duavee is not for women who can get pregnant.
How to Read This abiraterone vs bazedoxifene/conjugated estrogens Comparison
abiraterone is classified in the CYP17 Inhibitor drug class, while bazedoxifene/conjugated estrogens sits within the SERM / Estrogen Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abiraterone has 4,213 submissions while bazedoxifene/conjugated estrogens has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abiraterone and bazedoxifene/conjugated estrogens — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.